{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T12:52:32Z","timestamp":1769345552015,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00259-019-04658-0","type":"journal-article","created":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T01:02:32Z","timestamp":1577149352000},"page":"1713-1721","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Impact of body mass index on cardiac adrenergic derangement in heart failure patients: a 123I-mIBG imaging study"],"prefix":"10.1007","volume":"47","author":[{"given":"Klara","family":"Komici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Bencivenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Paolillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Formisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Assante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Marsico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"D\u2019Antonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"De Simini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Cittadini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dino Franco","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Cuocolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale Perrone","family":"Filardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9701-0437","authenticated-orcid":false,"given":"Giuseppe","family":"Rengo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,24]]},"reference":[{"key":"4658_CR1","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2009.05.015","volume":"54","author":"F Triposkiadis","year":"2009","unstructured":"Triposkiadis F, Karayannis G, Giamouzis G, et al. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol. 2009;54:1747\u201362.","journal-title":"J Am Coll Cardiol"},{"key":"4658_CR2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/CIRCRESAHA.113.300308","volume":"113","author":"A Lymperopoulos","year":"2013","unstructured":"Lymperopoulos A, Rengo G, Koch WJ. Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res. 2013;113:739\u201353.","journal-title":"Circ Res"},{"key":"4658_CR3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/14728222.2018.1406925","volume":"22","author":"A Cannavo","year":"2018","unstructured":"Cannavo A, Komici K, Bencivenga L, et al. GRK2 as a therapeutic target for heart failure. Expert Opin Ther Targets. 2018;22:75\u201383.","journal-title":"Expert Opin Ther Targets"},{"key":"4658_CR4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJM198207223070401","volume":"307","author":"MR Bristow","year":"1982","unstructured":"Bristow MR, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982;307:205\u201311.","journal-title":"N Engl J Med"},{"key":"4658_CR5","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/eurheartj\/ehi429","volume":"26","author":"G Iaccarino","year":"2005","unstructured":"Iaccarino G, Barbato E, Cipolletta E, et al. Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. Eur Heart J. 2005;26:1752\u20138.","journal-title":"Eur Heart J"},{"key":"4658_CR6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/CIRCRESAHA.107.168336","volume":"103","author":"PW Raake","year":"2008","unstructured":"Raake PW, Vinge LE, Gao E, et al. G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure. Circ Res. 2008;103:413\u201322.","journal-title":"Circ Res"},{"key":"4658_CR7","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.ejheart.2008.09.011","volume":"10","author":"T Tsutamoto","year":"2008","unstructured":"Tsutamoto T, Nishiyama K, Sakai H, et al. Transcardiac increase in norepinephrine and prognosis in patients with chronic heart failure. Eur J Heart Fail. 2008;10:1208\u201314.","journal-title":"Eur J Heart Fail"},{"key":"4658_CR8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ehj.2003.10.030","volume":"25","author":"R Latini","year":"2004","unstructured":"Latini R, Masson S, Anand I, et al. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J. 2004;25:292\u20139.","journal-title":"Eur Heart J"},{"key":"4658_CR9","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/CIRCRESAHA.115.308207","volume":"118","author":"G Rengo","year":"2016","unstructured":"Rengo G, Pagano G, Filardi PP, et al. Prognostic value of lymphocyte G protein-coupled receptor kinase-2 protein levels in patients with heart failure. Circ Res. 2016;118:1116\u201324.","journal-title":"Circ Res"},{"key":"4658_CR10","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1161\/CIRCRESAHA.114.302589","volume":"114","author":"VG Florea","year":"2014","unstructured":"Florea VG, Cohn JN. The autonomic nervous system and heart failure. Circ Res. 2014;114:1815\u201326.","journal-title":"Circ Res"},{"key":"4658_CR11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5114\/aoms.2010.13500","volume":"6","author":"A Zygmunt","year":"2010","unstructured":"Zygmunt A, Stanczyk J. Methods of evaluation of autonomic nervous system function. Arch Med Sci. 2010;6:11\u20138.","journal-title":"Arch Med Sci"},{"key":"4658_CR12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcmg.2009.09.015","volume":"3","author":"DM Raffel","year":"2010","unstructured":"Raffel DM, Wieland DM. Development of mIBG as a cardiac innervation imaging agent. J Am Coll Cardiol Cardiovasc Imaging. 2010;3:111\u20136.","journal-title":"J Am Coll Cardiol Cardiovasc Imaging"},{"key":"4658_CR13","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","volume":"55","author":"AF Jacobson","year":"2010","unstructured":"Jacobson AF, Senior R, Cerqueira MD, et al. Myocardial iodine-123 metaiodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart failure study). J Am Coll Cardiol. 2010;55:2212\u201321.","journal-title":"J Am Coll Cardiol"},{"key":"4658_CR14","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.2105\/AJPH.2016.303326","volume":"106","author":"A Hruby","year":"2016","unstructured":"Hruby A, Manson JE, Qi L, et al. Determinants and consequences of obesity. Am J Public Health. 2016;106:1656\u201362.","journal-title":"Am J Public Health"},{"key":"4658_CR15","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.ATV.0000216787.85457.f3","volume":"26","author":"P Poirier","year":"2006","unstructured":"Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol. 2006;26:968\u201376.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4658_CR16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/cob.12203","volume":"7","author":"RL Kolotkin","year":"2017","unstructured":"Kolotkin RL, Andersen JR. A systematic review of reviews: exploring the relationship between obesity, weight loss and health-related quality of life. Clin Obes. 2017;7:273\u201389.","journal-title":"Clin Obes"},{"key":"4658_CR17","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1152\/japplphysiol.00470.2003","volume":"96","author":"AB Vallbo","year":"2004","unstructured":"Vallbo AB, Hagbarth KE, Wallin BG. Microneurography: how the technique developed and its role in the investigation of the sympathetic nervous system. J Appl Physiol (1985). 2004;96:1262\u20139.","journal-title":"J Appl Physiol (1985)"},{"key":"4658_CR18","doi-asserted-by":"crossref","first-page":"H469","DOI":"10.1152\/ajpheart.2001.281.2.H469","volume":"281","author":"CE Negrao","year":"2001","unstructured":"Negrao CE, Trombetta IC, Batalha LT, et al. Muscle metaboreflex control is diminished in normotensive obese women. Am J Physiol Heart Circ Physiol. 2001;281:H469\u201375.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4658_CR19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.0000242642.42177.49","volume":"48","author":"M Esler","year":"2006","unstructured":"Esler M, Straznicky N, Eikelis N, Masuo K, Lambert G, Lambert E. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension. 2006;48:787\u201396.","journal-title":"Hypertension"},{"key":"4658_CR20","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.HYP.25.4.560","volume":"25","author":"G Grassi","year":"1995","unstructured":"Grassi G, Seravalle G, Cattaneo BM, et al. Sympathetic activation in obese normotensive subjects. Hypertension. 1995;25:560\u20133.","journal-title":"Hypertension."},{"key":"4658_CR21","first-page":"709","volume":"59","author":"I Tonhajzerova","year":"2008","unstructured":"Tonhajzerova I, Javorka M, Trunkvalterova Z, et al. Cardio-respiratory interaction and autonomic dysfunction in obesity. J Physiol Pharmacol. 2008;59:709\u201318.","journal-title":"J Physiol Pharmacol"},{"key":"4658_CR22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.amjcard.2003.09.065","volume":"93","author":"I Antelmi","year":"2004","unstructured":"Antelmi I, de Paula RS, Shinzato AR, et al. Influence of age, gender, body mass index, and functional capacity on heart rate variability in a cohort of subjects without heart disease. Am J Cardiol. 2004;93:381\u20135.","journal-title":"Am J Cardiol"},{"key":"4658_CR23","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1161\/01.CIR.96.10.3423","volume":"96","author":"M Vaz","year":"1997","unstructured":"Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation. 1997;96:3423\u20139.","journal-title":"Circulation"},{"key":"4658_CR24","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1007\/s00259-016-3432-3","volume":"43","author":"G Rengo","year":"2016","unstructured":"Rengo G, Pagano G, Vitale DF, et al. Impact of aging on cardiac sympathetic innervation measured by 123I-mIBG imaging in patients with systolic heart failure. Eur J Nucl Med Mol Imaging. 2016;43:2392\u2013400.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4658_CR25","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s00259-010-1491-4","volume":"37","author":"A Flotats","year":"2010","unstructured":"Flotats A, Carri\u00f3 I, Agostini D, et al. EANM Cardiovascular Committee; European Council of Nuclear Cardiology. Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging. 2010;37:1802\u201312.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4658_CR26","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.2337\/dc12-2147","volume":"36","author":"S Paolillo","year":"2013","unstructured":"Paolillo S, Rengo G, Pagano G, et al. Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I metaiodobenzylguanidine (123I MIBG) scintigraphic study. Diabetes Care. 2013;36:2395\u2013401.","journal-title":"Diabetes Care"},{"key":"4658_CR27","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00259-013-2461-4","volume":"40","author":"T Pellegrino","year":"2013","unstructured":"Pellegrino T, Petretta M, De Luca S, et al. Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure. Eur J Nucl Med Mol Imaging. 2013;40:1549\u201357.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4658_CR28","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2147\/CIA.S135676","volume":"12","author":"K Komici","year":"2017","unstructured":"Komici K, Vitale DF, Leosco D, et al. Pressure injuries in elderly with acute myocardial infarction. Clin Interv Aging. 2017;12:1495\u2013501.","journal-title":"Clin Interv Aging"},{"key":"4658_CR29","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/ije\/28.5.964","volume":"28","author":"P Royston","year":"1999","unstructured":"Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 1999;28:964\u201374.","journal-title":"Int J Epidemiol"},{"key":"4658_CR30","doi-asserted-by":"crossref","first-page":"e0216507","DOI":"10.1371\/journal.pone.0216507","volume":"14","author":"B Lanzillo","year":"2019","unstructured":"Lanzillo B, Piscosquito G, Marcuccio L, Lanzillo A, Vitale DF. Prognosis of severe acquired brain injury: short and long-term outcome determinants and their potential clinical relevance after rehabilitation. A comprehensive approach to analyze cohort studies. PLoS One. 2019;14:e0216507.","journal-title":"PLoS One"},{"key":"4658_CR31","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/oxfordjournals.aje.a008670","volume":"143","author":"FJ Nieto","year":"1996","unstructured":"Nieto FJ, Coresh J. Adjusting survival curves for confounders: a review and a new method. Am J Epidemiol. 1996;143:1059\u201368.","journal-title":"Am J Epidemiol"},{"key":"4658_CR32","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/ehjci\/jey016","volume":"19","author":"K Nakajima","year":"2018","unstructured":"Nakajima K, Nakata T, Doi T, et al. Validation of 2-year 123I-meta-iodobenzylguanidine-based cardiac mortality risk model in chronic heart failure. Eur Heart J Cardiovasc Imaging. 2018;19:749\u201356.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"4658_CR33","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","volume":"113","author":"WC Levy","year":"2006","unstructured":"Levy WC, Mozaffarian D, Linker DT, et al. The Seattle heart failure model: prediction of survival in heart failure. Circulation. 2006;113:1424\u201333.","journal-title":"Circulation."},{"key":"4658_CR34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3389\/fphys.2017.00665","volume":"8","author":"D Guarino","year":"2017","unstructured":"Guarino D, Nannipieri M, Iervasi G, Taddei S, Bruno RM. The role of the autonomic nervous system in the pathophysiology of obesity. Front Physiol. 2017;8:665.","journal-title":"Front Physiol"},{"key":"4658_CR35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000177118","volume":"87","author":"S Ferraro","year":"1996","unstructured":"Ferraro S, Perrone-Filardi P, Desiderio A, et al. Left ventricular systolic and diastolic function in severe obesity: a radionuclide study. Cardiology. 1996;87:347\u201353.","journal-title":"Cardiology"},{"key":"4658_CR36","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jacc.2011.11.034","volume":"59","author":"MC Brandt","year":"2012","unstructured":"Brandt MC, Mahfoud F, Reda S, et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol. 2012;59:901\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"4658_CR37","first-page":"822","volume":"5","author":"T Pellegrino","year":"2015","unstructured":"Pellegrino T, Piscopo V, Boemio A, et al. Impact of obesity and acquisition protocol on (123)I-metaiodobenzylguanidine indexes of cardiac sympathetic innervation. Quant Imaging Med Surg. 2015;5:822\u20138.","journal-title":"Quant Imaging Med Surg"},{"key":"4658_CR38","doi-asserted-by":"crossref","first-page":"H2543","DOI":"10.1152\/ajpheart.01201.2006","volume":"293","author":"AM Schreihofer","year":"2007","unstructured":"Schreihofer AM, Mandel DA, Mobley SC, Stepp DW. Impairment of sympathetic baroreceptor reflexes in obese Zucker rats. AmJ Physiol Heart Circ Physiol. 2007;293:H2543\u20139.","journal-title":"AmJ Physiol Heart Circ Physiol"},{"key":"4658_CR39","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/01.HYP.36.4.538","volume":"36","author":"G Grassi","year":"2000","unstructured":"Grassi G, Seravalle G, Dell\u2019Oro R, Turri C, Bolla GB, Mancia G. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension. 2000;36:538\u201342.","journal-title":"Hypertension"},{"key":"4658_CR40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2337\/db09-0934","volume":"59","author":"NE Straznicky","year":"2010","unstructured":"Straznicky NE, Lambert EA, Nestel PJ, et al. Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects. Diabetes. 2010;59:71\u20139.","journal-title":"Diabetes"},{"key":"4658_CR41","doi-asserted-by":"crossref","first-page":"H244","DOI":"10.1152\/ajpheart.00096.2015","volume":"309","author":"EA Lambert","year":"2015","unstructured":"Lambert EA, Straznicky NE, Dixon JB, Lambert GW. Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity? Am J Physiol Heart Circ Physiol. 2015;309:H244\u201358.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4658_CR42","first-page":"959","volume":"16","author":"JB Young","year":"1992","unstructured":"Young JB, Macdonald IA. Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int J Obes Relat Metab Disord. 1992;16:959\u201367.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"4658_CR43","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/01.HYP.36.5.824","volume":"36","author":"MS Rumantir","year":"2000","unstructured":"Rumantir MS, Kaye DM, Jennings GL, Vaz M, Hastings JA, Esler MD. Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension. Hypertension. 2000;36:824\u20139.","journal-title":"Hypertension"},{"key":"4658_CR44","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/ehjci\/jev295","volume":"17","author":"IP Clements","year":"2016","unstructured":"Clements IP, Kelkar AA, Garcia EV, et al. Prognostic significance of (123)I-mIBG SPECT myocardial imaging in heart failure: differences between patients with ischaemic and non-ischaemic heart failure. Eur Heart J Cardiovasc Imaging. 2016;17:384\u201390.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"4658_CR45","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/MNM.0b013e328344dfed","volume":"32","author":"BE Chrapko","year":"2011","unstructured":"Chrapko BE, Jaroszy\u0144ski AJ, G\u0142owniak A, Bednarek-Skublewska A, Za\u0142uska W, Ksia\u017cek A. Iodine-123 metaiodobenzylguanidine myocardial imaging in haemodialysed patients asymptomatic for coronary artery disease: a preliminary report. Nucl Med Commun. 2011;32:515\u201321.","journal-title":"Nucl Med Commun"},{"key":"4658_CR46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s41747-017-0027-0","volume":"1","author":"W Noordzij","year":"2017","unstructured":"Noordzij W, \u00d6zyilmaz A, Glaudemans AWJM, Tio RA, Goet ER, Franssen CFM, et al. Investigation into cardiac sympathetic innervation during the commencement of haemodialysis in patients with chronic kidney disease. Eur Radiol Exp. 2017;1:24.","journal-title":"Eur Radiol Exp"},{"key":"4658_CR47","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2967\/jnumed.111.095786","volume":"53","author":"T Doi","year":"2012","unstructured":"Doi T, Nakata T, Hashimoto A, et al. Cardiac mortality assessment improved by evaluation of cardiac sympathetic nerve activity in combination with hemoglobin and kidney function in chronic heart failure patients. Nucl Med. 2012;53:731\u201340.","journal-title":"Nucl Med"},{"key":"4658_CR48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/MNM.0000000000000017","volume":"35","author":"S Malhotra","year":"2014","unstructured":"Malhotra S, Wang L, Bunker CH, Winger D, Soman P. Renal dysfunction does not affect the prognostic value of myocardial iodine-123 meta-iodobenzylguanidine imaging in heart failure. Nucl Med Commun. 2014;35:58\u201363.","journal-title":"Nucl Med Commun"},{"key":"4658_CR49","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1093\/eurheartj\/ehv350","volume":"36","author":"P Perrone Filardi","year":"2015","unstructured":"Perrone Filardi P, Paolillo S, Costanzo P, Savarese G, Trimarco B, Bonow RO. The role of metabolic syndrome in heart failure. Eur Heart J. 2015;36:2630\u20134.","journal-title":"Eur Heart J"},{"key":"4658_CR50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jchf.2013.01.006","volume":"1","author":"CJ Lavie","year":"2013","unstructured":"Lavie CJ, Alpert MA, Arena R, Mehra MR, Milani RV, Ventura HO. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail. 2013;1:93\u2013102.","journal-title":"JACC Heart Fail"},{"key":"4658_CR51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ahj.2008.02.014","volume":"156","author":"A Oreopoulos","year":"2008","unstructured":"Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J. 2008;156:13\u201322.","journal-title":"Am Heart J"},{"key":"4658_CR52","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0002-9149(03)00031-6","volume":"91","author":"CJ Lavie","year":"2003","unstructured":"Lavie CJ, Osman AF, Milani RV, Mehra MR. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol. 2003;91:891\u20134.","journal-title":"Am J Cardiol"},{"key":"4658_CR53","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.jacc.2014.09.067","volume":"64","author":"U Khalid","year":"2014","unstructured":"Khalid U, Ather S, Bavishi C, et al. Pre-morbid body mass index and mortality after incident heart failure: the ARIC study. J Am Coll Cardiol. 2014;64:2743\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"4658_CR54","doi-asserted-by":"crossref","first-page":"e2016025","DOI":"10.4178\/epih.e2016025","volume":"38","author":"M Shakiba","year":"2016","unstructured":"Shakiba M, Soori H, Mansournia MA, Nazari SS, Salimi Y. Adjusting for reverse causation to estimate the effect of obesity on mortality after incident heart failure in the Atherosclerosis Risk in Communities (ARIC) study. Epidemiol Health. 2016;38:e2016025.","journal-title":"Epidemiol Health"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04658-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-019-04658-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04658-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T00:24:40Z","timestamp":1608683080000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-019-04658-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,24]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["4658"],"URL":"https:\/\/doi.org\/10.1007\/s00259-019-04658-0","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,24]]},"assertion":[{"value":"6 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee (Ethical Committee \u201cCarlo Romano,\u201d University of Naples \u201cFederico II,\u201d number 50\/13) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}